Nordicus Partners Corporation (NORD) Fair Value & Analysis
Industrials · US · Market cap $47.2M
Nordicus Partners Corporation
NORD · US
Fair value as of: Jul 24, 2026
From 1 valuation models · updated 17 days ago
Share price −16.7% over the past month.
Below-average quality, and screening another 26% overvalued on our models.
What matters now
- Weak quality (13/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range ($1.34 to $2.69) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.
How to read this chart
60‑month range $0.2000 – $25.00 · fair‑value band $1.34 – $2.69 · the $2.45 price screens above the $1.80 fair value. Dashed = 300-day average. As of Jul 24, 2026.
Analysis
Nordicus Partners Corporation (NORD) currently trades at $2.45, while our model-based Fair Value estimate is $1.80, implying the stock looks roughly 26.5% overvalued today. The Quality Score stands at 13/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
It earns a return on equity of -7.4%. Fundamentals as of Jul 24, 2026
Our scenario range runs from $1.34 (bear case) to $2.69 (bull case); at $2.45, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 59% below its 52-week high and 96% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -15% fair-value upside, at -26%, NORD screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when NORD reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 19 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health.
Full company description
Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2016 – FY2025 · reported fiscal years
Nordicus Partners Corporation reported revenue of $5.0K in FY2025 versus $856M in FY2016, a compound −73.8%/yr. Reported net income was −$2.9M in FY2025.
NORD screens 26% overvalued. Compare with Verisk Analytics, Inc →
Peer Group
Consulting Services · 82 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Consulting Services median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Verisk Analytics, Inc VRSK | $201.49 | $145.58 | -28% |
| SGS SA SGSN | CHF 94.68 | CHF 68.96 | -27% |
| Equifax Inc EFX | $177.08 | $101.34 | -43% |
| Bureau Veritas SA BVI | €27.20 | €27.81 | +2% |
| ALS Limited ALQ | A$21.96 | A$11.02 | -50% |
| Booz Allen Hamilton Holding BAH | $63.94 | $120.62 | +89% |
| DKSH Holding DKSH | CHF 67.60 | CHF 64.81 | -4% |
| FTI Consulting, Inc FCN | $156.86 | $171.64 | +9% |
| Centre Testing International Group 300012 | ¥14.06 | ¥11.90 | -15% |
| GRG Metrology & Test Group 002967 | ¥16.56 | ¥11.69 | -29% |
Compare Nordicus Partners Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Nordicus Partners Corporation (NORD) overvalued or undervalued?
What is the fair value of NORD?
What is the quality score of NORD?
What is the net profit margin of NORD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Nordicus Partners Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.